M&A Deal Summary

ATHOS Acquires Schülke

On August 7, 2023, family office ATHOS acquired life science company Schülke from EQT

Acquisition Highlights
  • This is ATHOS’s 1st transaction in the Life Science sector.
  • This is ATHOS’s 1st transaction in Germany.

M&A Deal Summary

Date 2023-08-07
Target Schülke
Sector Life Science
Buyer(s) ATHOS
Sellers(s) EQT
Deal Type Secondary Buyout

Target

Schülke

Norderstedt, Germany
Schülke develops, produces, and distributes antiseptics for wound care, disinfectants, medical and cosmetic skin care products, and preservatives. The company offers its customers innovative products, technologies, and services in its core business fields: healthcare, industrial hygiene, and personal care. Schülke was formed in 1889 and is based in Norderstedt, Germany.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

DESCRIPTION

ATHOS is a Munich based single family office. ATHOS with its heritage in healthcare and life sciences invests in teams with exceptional science expertise and technology-driven companies with an entrepreneurial and value-based approach. ???????ATHOS is based in Munich, Germany.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Secondary Buyout M&A Deals 1 of 1
Country: Germany M&A 1 of 1
Year: 2023 M&A 1 of 1

Seller(S) 1

SELLER

EQT

Stockholm, Sweden

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1994
PE ASSETS 242.0B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

EQT is a global private equity group that purses a variety of investment strategies around the world. EQT is divided into several investment disciplines, including private capital, real assets, credit, and venture. The Firm's private capital group targets large, market-leading enterprises (investment size of €125 to €1.5 billion) across Europe and the US, as well as mid-market, growth companies (investment size of €40 to €125 million) across the US, Europe, China, and Southeast Asia. The Firm's real assets group seeks to identify control or co-control equity investments (investment size of €500 to €1 billion) in medium-sized infrastructure companies that provide an essential service to society, are recession resilient, and have secure cash flows. EQT's credit group provides flexible, long-term debt capital solutions to medium-sized European businesses, across a wide range of sectors. EQT was established in 1994 and is headquartered in Stockholm, Sweden.


DEAL STATS #
Overall 177 of 194
Sector: Life Science M&A 7 of 8
Type: Secondary Buyout M&A Deals 54 of 61
Country: Germany M&A 33 of 34
Year: 2023 M&A 7 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-07-20 Dechra Pharmaceuticals

Northwich, United Kingdom

Dechra Pharmaceuticals is an international specialist in veterinary pharmaceuticals and related products business. Its expertise is in the development, manufacturing, sales, and marketing of quality products exclusively for veterinarians worldwide. The company's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. Dechra Pharmaceuticals was founded in 1997 and is based in Northwich, United Kingdom.

Buy £4.5B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-09-04 Dataflow Group

Dubai, United Arab Emirates

Dataflow Group helps clients to conduct primary source verification (PSV) on credentials of highly skilled professionals, for example, doctors, nurses, or engineers, as part of mandatory immigration and credentialing programs, and processes hundreds of thousands of immigration compliance screening and verification service transactions for professionals each year on behalf of the government, quasigovernment, regulatory and large multinational organizations worldwide. Dataflow Group was founded in 2006 and is based in Dubai, United Arab Emirates.

Sell -